863 MITTEN ROAD, BURLINGAME, CA
Market cap: $570.3M (12/17/2025)
Price: $7.64
Provides Business Update and Reports Third Quarter 2025 Financial Results
Changes in Board, Management or Compensation
Earnings Release
Shareholder votes
Announces Full Data from Cohort 3 of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis
Provides Business Update and Reports First Quarter 2025 Financial Results
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results
Q3
Q2
Q1
FY 2024
FY 2023
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Prospectus filed pursuant to Rule 424(b)(5)
Additional Proxy Materials
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
Initial Statement of Beneficial Ownership
Correspondence
Submission Upload